Data / Drug companies / Formosa Laboratories, Inc.
Formosa Laboratories, Inc.: 33 products in the FDA NDC directory, labeler code 66499
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Formosa Laboratories, Inc. (labeler code 66499) lists 33 products in the FDA National Drug Code Directory. By type: 33 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 16, 2025.
The request: Watch Formosa Laboratories, Inc. (FDA labeler code 66499): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66499
- Products in commercial distribution
- 33
- Packages
- 33
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 31, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 32 | 97% |
| Liquid | 1 | 3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Xav-939 | 66499-0080 | Powder | Bulk ingredients | January 16, 2025 |
| Mycophenolate sodium | 66499-0039 | Powder | Bulk ingredients | January 22, 2021 |
| Eribulin mesylate | 66499-0074 | Powder | Bulk ingredients | November 30, 2020 |
| Elagolix sodium | 66499-0072 | Powder | Bulk ingredients | August 19, 2020 |
| Gadoterate meglumine | 66499-0066 | Powder | Bulk ingredients | September 9, 2019 |
| Patiromer sorbitex calcium | 66499-0063 | Powder | Bulk ingredients | August 24, 2018 |
| Nintedanib esylate | 66499-0062 | Powder | Bulk ingredients | April 26, 2018 |
| Nintedanib | 66499-0061 | Powder | Bulk ingredients | April 26, 2018 |
| Dinalbuphine sebacate | 66499-0060 | Powder | Bulk ingredients | April 26, 2018 |
| Teriflunomide | 66499-0059 | Powder | Bulk ingredients | April 14, 2015 |
| Linezolid | 66499-0047 | Powder | Bulk ingredients | December 2, 2014 |
| Benzonatate | 66499-0068 | Liquid | Bulk ingredients | September 26, 2014 |
| Mycophenolate mofetil | 66499-0006 | Powder | Bulk ingredients | September 26, 2014 |
| Calcitriol | 66499-0003 | Powder | Bulk ingredients | September 26, 2014 |
| Tasimelteon | 66499-0054 | Powder | Bulk ingredients | January 17, 2014 |
| Leflunomide | 66499-0001 | Powder | Bulk ingredients | January 17, 2014 |
| Mifepristone | 66499-0056 | Powder | Bulk ingredients | August 23, 2013 |
| Levonorgestrel | 66499-0018 | Powder | Bulk ingredients | February 22, 2013 |
| Pazopanib hydrochloride | 66499-0055 | Powder | Bulk ingredients | April 23, 2012 |
| Ergocalciferol | 66499-0041 | Powder | Bulk ingredients | February 5, 2010 |
| Iloperidone | 66499-0067 | Powder | Bulk ingredients | January 21, 2010 |
| Iloperidone | 66499-0042 | Powder | Bulk ingredients | January 21, 2010 |
| Capsaicin | 66499-0036 | Powder | Bulk ingredients | May 12, 2009 |
| Calcipotriol monohydrate | 66499-0024 | Powder | Bulk ingredients | September 12, 2008 |
| Sevelamer carbonate | 66499-0023 | Powder | Bulk ingredients | July 3, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.